Mostrar el registro sencillo del ítem

dc.contributor.authorCorton, M.
dc.contributor.authorAvila-Fernandez, A.
dc.contributor.authorVallespín, E.
dc.contributor.authorLópez-Molina, M. I.
dc.contributor.authorAlmoguera, B.
dc.contributor.authorMartín-Garrido, E.
dc.contributor.authorTatu, S. D.
dc.contributor.authorKhan, M. I.
dc.contributor.authorBlanco-Kelly, F.
dc.contributor.authorRiveiro-Alvarez, R.
dc.contributor.authorBrión Martínez, María José 
dc.contributor.authorGarcía-Sandoval, B.
dc.contributor.authorCremers, F. P.
dc.contributor.authorCarracedo Álvarez, Ángel
dc.contributor.authorAyuso, C.
dc.date.accessioned2017-06-07T07:16:12Z
dc.date.available2017-06-07T07:16:12Z
dc.date.issued2014
dc.identifier.issn0161-6420
dc.identifier.urihttp://hdl.handle.net/20.500.11940/4546
dc.description.abstractOBJECTIVE: We aimed to identify novel genetic defects in the LCA5 gene underlying Leber congenital amaurosis (LCA) in the Spanish population and to describe the associated phenotype. DESIGN: Case series. PARTICIPANTS: A cohort of 217 unrelated Spanish families affected by autosomal recessive or isolated retinal dystrophy, that is, 79 families with LCA and 138 families with early-onset retinitis pigmentosa (EORP). A total of 100 healthy, unrelated Spanish individuals were screened as controls. METHODS: High-resolution homozygosity mapping was performed in 44 patients with LCA using genome-wide single nucleotide polymorphism (SNP) microarrays. Direct sequencing of the LCA5 gene was performed in 5 patients who showed homozygous regions at chromosome 6 and in 173 unrelated individuals with LCA or EORP. The ophthalmic history of 8 patients carrying LCA5 mutations was reviewed and additional examinations were performed, including electroretinography (ERG), optical coherence tomography (OCT), and fundus photography. MAIN OUTCOME MEASURES: Single nucleotide polymorphism genotyping, identity-by-descent (IBD) regions, LCA5 mutations, best-corrected visual acuity, visual field assessments, fundus appearance, ERG, and OCT findings. RESULTS: Four novel and 2 previously reported LCA5 mutations have been identified in 6 unrelated families with LCA by homozygosity mapping or Sanger sequencing. Thus, LCA5 mutations have a frequency of 7.6% in the Spanish population. However, no LCA5 mutations were found in 138 patients with EORP. Although most of the identified LCA5 mutations led to a truncated protein, a likely pathogenic missense variant was identified for the first time as a cause of LCA, segregating in 2 families. We also have characterized a novel splicing site mutation at the RNA level, demonstrating that the mutant LCA5 transcript was absent in a patient. All patients carrying LCA5 mutations presented nystagmus, night blindness, and progressive loss of visual acuity and visual field leading to blindness toward the third decade of life. Fundoscopy showed fundus features of pigmentary retinopathy with atrophic macular lesions. CONCLUSIONS: This work reveals a higher frequency of LCA5 mutations in a Spanish LCA cohort than in other populations. This study established gene-specific frequencies and the underlying phenotype of LCA5 mutations in the Spanish population.
dc.language.isoeng
dc.subject.meshAdult
dc.subject.meshChild
dc.subject.meshChromosomes, Human, Pair 6
dc.subject.meshElectroretinography
dc.subject.meshEye Proteins
dc.subject.meshGene Frequency
dc.subject.meshGenome-Wide Association Study
dc.subject.meshGenotyping Techniques
dc.subject.meshHumans
dc.subject.meshLeber Congenital Amaurosis
dc.subject.meshMicroarray Analysis
dc.subject.meshMicrotubule-Associated Proteins
dc.subject.meshMutation, Missense
dc.subject.meshPhenotype
dc.subject.meshPolymorphism, Single Nucleotide
dc.subject.meshRetinitis Pigmentosa
dc.subject.meshReverse Transcriptase Polymerase Chain Reaction
dc.subject.meshSpain
dc.subject.meshVisual Acuity
dc.subject.meshVisual Fields
dc.subject.meshYoung Adult
dc.titleInvolvement of LCA5 in Leber congenital amaurosis and retinitis pigmentosa in the Spanish population
dc.typeArtigoes
dc.authorsophosCorton, M.
dc.authorsophosAvila-Fernandez, A.
dc.authorsophosVallespín, E.
dc.authorsophosLópez-Molina, M. I.
dc.authorsophosAlmoguera, B.
dc.authorsophosMartín-Garrido, E.
dc.authorsophosTatu, S. D.
dc.authorsophosKhan, M. I.
dc.authorsophosBlanco-Kelly, F.
dc.authorsophosRiveiro-Alvarez, R.
dc.authorsophosBrión, M.
dc.authorsophosGarcía-Sandoval, B.
dc.authorsophosCremers, F. P.
dc.authorsophosCarracedo, A.
dc.authorsophosAyuso, C.
dc.identifier.doi10.1016/j.ophtha.2013.08.028
dc.identifier.isi329169500062
dc.identifier.pmid24144451
dc.identifier.sophos14614
dc.issue.number1
dc.journal.titleOPHTHALMOLOGY
dc.organizationServizo Galego de Saúde::Estrutura de Xestión Integrada (EOXI)::EOXI de Santiago::IDIS.- Instituto de investigaciones sanitarias de Santiago
dc.organizationConsellería de Sanidade::Fundación pública Galega de Medicina Xenómica
dc.page.initial399
dc.page.final407
dc.rights.accessRightsopenAccess
dc.typesophosArtículo Original
dc.volume.number121


Ficheros en el ítem

Este ítem aparece en la(s) siguiente(s) colección(ones)

Mostrar el registro sencillo del ítem